Form D · Pharmaceuticals

Auris Medical Holding AG

6300 Zug, V8 · CIK 0001601936

Offering snapshot reported Feb 9, 2018 · SEC filing

Reported sold
$5.5M
Offering amount: $5.5M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 26, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 9, 2018Initial$5,499,999No comparison8SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$385K
Finders' fees
$0
Form D file number
021-305328
The total offering amount includes the concurrent registered offering of common shares.
Sales commissions relates to commissions for the sale of common shares in the concurrent registered offering.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Ladenburg Thalmann & Co. Inc.505

Source: Form D, filed Feb 9, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Armando Anido Director
Mats Blom Director
Andrea Braun Executive
Oliver Kubli Director
Hernan Levett Executive
Thomas Meyer Director, Executive
Berndt A. Modig Director
Calvin W Roberts Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
Bahnhofstrasse 21
6300 Zug, V8, 00000